WellTheory is a virtual care platform dedicated to addressing the autoimmune epidemic by focusing on the root causes of autoimmunity and providing comprehensive, whole-person care. The platform offers a research-backed program that aims to reduce symptoms, improve quality of life, and lower healthcare costs through evidence-based, high-touch care led by an interdisciplinary team of experts. WellTheory's approach integrates medical treatment, medication management, and lifestyle modifications, utilizing AI-enabled personalization to deliver tailored care solutions at scale.
WellTheory had 73 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
WellTheory had 15,674 followers as of October 12, 2026. The number of followers increased by 138 (0.89%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 14, 2025 | Series A | $14.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Ingeborg Investments | Series A |
| General Catalyst | Series A |
| Accel | Series A |
| 7Wire Ventures | Series A |
| Leaps by Bayer | Series A |
| Box Group | Series A |
| Up2 Opportunity Fund | Series A |
A snapshot of private companies similar to WellTheory, helping you discover and navigate related company profiles.

